Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
The British Journal of Surgery|February 20, 2021
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trialF Fitzal, M Filipits, C Fesl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
The impact of hemoglobin levels on fatigue and quality of life in cancer patientsB Holzner, G Kemmler, R Greil, et al.The Pharmacogenomics Journal|May 4, 2016
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancerS P Gampenrieder, C Hufnagl, S Brechelmacher, et al.European Journal of Immunology|November 11, 1999
Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cellsA Villunger, N Ghaffari-Tabrizi, I Tinhofer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsS Kubicka, R Greil, T André, et al.European Journal of Cancer (Oxford, England : 1990)|May 30, 2012
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancerI Lang, M J Inbar, Z Kahán, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2018
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patientsA Matikas, T Foukakis, V Moebus, et al.British Journal of Cancer|May 31, 2014
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patientsK T Troppan, K Schlick, A Deutsch, et al.Oncogene|July 7, 2010
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cellsP Desch, D Asslaber, D Kern, et al.ESMO Open|March 25, 2022
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18C Minichsdorfer, T Fuereder, M Leutner, et al.Pageof 12